Scroll To Top
Search by Speciality

8th Annual Pain Therapeutics Summit 2014

Embassy Suites San Diego Bay * | San francisco, USA
From 1795 to 350 USD
Event Preview
This event
is Finished
Title: 8th Annual Pain Therapeutics Summit 2014
Specialty: , Anesthesiology
Dates: From Nov, 5, 2014 to Nov, 6, 2014
Location: San francisco, USA
Type: Summit
Registration Cost: From 1795 to 350 USD
Event Tools
  • Add to Favorites
  • Claim this event
Add to my Calendar
  • Scientific Programm
  • Online registration
  • Exhibition floorplans
  • Sponsorship &
    Exhibition consensus
  • Virtual Booths
Weather Info (monthly averages) Max Temperature: C / F Min Temperature: C / F The above data in our Weather Info table are temperature predictions for the date of the medical event for San Francisco, Usa.
General Info
Event Venue:

Embassy Suites San Diego Bay *

San Francisco, USA Visit the Venue to read more
Event Overview
Welcome message:

ARROWHEAD’S ANNUAL PAIN & MIGRAINE THERAPEUTICS SUMMIT is the US’s premier pain conference covering the field of pain research and therapeutics. Leaders from the pharmaceutical, biotech, device and medical communities attend this conference to learn about the latest advances in the treatment of various types of pain and to network with colleagues from industry, the non-profit sector, academia, the medical community, government and investors.

This conference provides attendees with thoughtful insight from key industry leaders and academic researchers concerning cutting edge drug discovery science, preclinical development trends, analysis of key clinical-stage pain therapies and newly marketed products. We will highlight the most important developments in recent years in the field, including new research in genome-wide association studies, CGRP antagonists, NGF antagonists, sodium and calcium channel blockers, new research in biologic therapies, the genetic components of pain, abuse-resistant opioids, analysis of FDA’s REMS program and a plethora of other topics.



  • Analysis of new drug discovery targets
  • Real-time fMRI (functional magnetic resonance imaging) for pain
  • Analysis of NGF antagonist clinical development programs
  • Exploration and analysis of animal models for pain
  • Gene therapy for pain
  • Sodium and calcium channel blockers in pre-clinical & clinical development
  • Challenges of pain clinical trials
  • Endpoints in pain clinical trials
  • Molecular tools for dissecting pain pathways
  • Abuse-resistant opioids in clinical development
  • Clinical development status of longer-acting analgesics for post-operative pain
  • Review and analysis of key developmental stage therapies for nociceptive pain, neuropathic pain, migraine, back pain, fibromyalgia, cancer pain, arthritic pain, acute pain and chronic pain
  • The future role of pharmacogenomics, biomarkers and translational research in the development of therapeutics for pain
  • Analysis and case studies of successful commercialization strategies for pain therapies
  • Genome-wide association studies of pain
schmidt CHAIR: William K. Schmidt, Ph.D.
President, NorthStar Consulting, LLC, VP Clinical & Regulatory, Arcion Therapeutics, VP Clinical & Regulatory, Api Genesis, LLC, VP Clinical Development, EicOsis, LLC
arneric Stephen Arneric, Ph.D.
Senior Research Fellow, Pain & Migraine Drug Hunting Team, Neuroscience Discovery, Eli Lilly & Co.
Mickle Travis Mickle, Ph.D.
President, CEO, KemPharm, Inc.
iadarola Michael Iadarola, Ph.D. (tentative)
Senior Research Scientist, Anesthesiology Research Laboratories, Department of Perioperative Medicine, Clinical Center, National Institutes of Health
kopecky Ernest Kopecky, Ph.D., MBA
VP, Clinical Development, Head, Neuroscience TA, Collegium Pharmaceutical, Inc.
charlesII Andrew Charles, MD
Professor, Meyer and Renee Luskin Chair in Migraine and Headache Studies, Director, Headache Research and Treatment Program, Department of Neurology, UCLA School of Medicine
bilsky1 Edward Bilsky, Ph.D.
Vice President for Research and Scholarship, Professor of Pharmacology, Director of the Center for Excellence in the Neurosciences, University of New England
cesare Paolo Cesare, Ph.D.
Department of Electrophysiology, Natural and Medical Sciences Institute at the University of Tübingen, NMI
katz Nathaniel Katz, MD
President, Analgesic Solutions
 hammock Bruce Hammock, Ph.D.
Distinguished Professor, Department of Entomology & UCD Comprehensive Cancer Center, PI, NIH Biotechnology Training Program, UC Davis
bigal Marcelo Bigal, MD, Ph.D.
Chief Medical Officer, Labrys Biologics, Inc.
parsons C. Lowell Parsons, MD
Professor of Surgery/Urology, School of Medicine, UC San Diego
 imagecomingsoon Jonathan Violin, Ph.D.
Director of Biology and Co-founder, Trevena, Inc.
singla Neil Singla, MD
Founder and Chief Scientific Officer, Lotus Clinical Research, LLC
imagecomingsoon Gavril Pasternak, MD, Ph.D.
Anne Burnett Tandy Chair in Neurology, Laboratory Head, Molecular Pharmacology and Chemistry Program,Memorial Sloan-Kettering Cancer Center
watkins Linda Watkins, Ph.D.
Distinguished Professor, Department of Psychology & Neuroscience and Center for Neuroscience, University of Colorado, Co-Chair, Advisory Board, Xalud Therapeutics, Inc.
hankin Cheryl Hankin, Ph.D.
President and Chief Scientific Officer, BioMedEcon, LLC
imagecomingsoon Mikhail "Mike" Nemenov, Ph.D.
Founder, President and Chief Scientist, Lasmed, LLC, Consulting Professor, Pain Research Center, Anesthesia Department, Stanford University
cummins Ted Cummins, Ph.D.
Associate Professor and Interim Chair, Department of Pharmacology and Toxicology, Indiana University School of Medicine
sabbadini Roger Sabbadini, Ph.D.
Vice President & Founder, Lpath, Inc.
Registration Not yet available Register Now

Embassy Suites San Diego Bay - Downtown
601 Pacific Highway
San Diego, California 92101

TEL: 1-619-239-2400
FAX: 1-619-239-1520


A guest room block at the Embassy Suites is available for this conference. Please CLICK HEREto book your room. The group code for booking is PTS.


Scientific Content Up to Date
Sponsors Exhibitors
Organising Agency
5780 Lincoln Drive
Suite 142
United States


Telephone: 866-945-0263
Fax: 866-945-0263

Event map
Revelant Events